OCRELIZUMAB AND HYALURONIDASE

OCRELIZUMAB AND HYALURONIDASE was reported 499 times

These side effects are most commonly reported by patients taking OCRELIZUMAB AND HYALURONIDASE:

# Side effect Count
0 INJECTION SITE PAIN 66
1 INJECTION SITE ERYTHEMA 53
2 FATIGUE 48
3 PAIN 40
4 NO ADVERSE EVENT 29
5 OFF LABEL USE 29
6 HEADACHE 25
7 MULTIPLE SCLEROSIS RELAPSE 25
8 RASH 24
9 CONTUSION 23
10 ERYTHEMA 22
11 INJECTION SITE REACTION 22
12 SWELLING 18
13 INJECTION SITE SWELLING 16
14 PRURITUS 14
15 PAIN IN EXTREMITY 13
16 DRUG INEFFECTIVE 12
17 ABDOMINAL PAIN 11
18 INJECTION SITE BRUISING 10
19 NAUSEA 10
20 BACK PAIN 9
21 FLUSHING 9
22 INFUSION RELATED REACTION 9
23 INJECTION SITE PRURITUS 9
24 MALAISE 9
25 MULTIPLE SCLEROSIS 9
26 PARAESTHESIA 9
27 THROAT IRRITATION 9
28 HYPOAESTHESIA 8
29 URTICARIA 8
30 BRAIN FOG 7
31 BURNING SENSATION 7
32 DIARRHOEA 7
33 INFLUENZA LIKE ILLNESS 7
34 INJECTION SITE RASH 7
35 INSOMNIA 7
36 MUSCULAR WEAKNESS 7
37 URINARY TRACT INFECTION 7
38 VOMITING 7
39 ABDOMINAL DISTENSION 6
40 ABDOMINAL PAIN LOWER 6
41 ARTHRALGIA 6
42 MIGRAINE 6
43 NASOPHARYNGITIS 6
44 THROAT TIGHTNESS 6
45 ASTHENIA 5
46 BLOOD PRESSURE DECREASED 5
47 DISCOMFORT 5
48 DIZZINESS 5
49 DRUG HYPERSENSITIVITY 5
50 DYSPNOEA 5
51 FALL 5
52 GAIT DISTURBANCE 5
53 HYPERSENSITIVITY 5
54 INJECTION RELATED REACTION 5
55 INJECTION SITE DISCHARGE 5
56 PNEUMONIA 5
57 PRODUCT STORAGE ERROR 5
58 PYREXIA 5
59 ABDOMINAL DISCOMFORT 4
60 ANAPHYLACTIC REACTION 4
61 ANXIETY 4
62 BLOOD GLUCOSE INCREASED 4
63 COLD SWEAT 4
64 COUGH 4
65 COVID-19 4
66 DYSPHONIA 4
67 ILLNESS 4
68 INJECTION SITE DISCOLOURATION 4
69 NASAL CONGESTION 4
70 PALPITATIONS 4
71 SKIN DISCOLOURATION 4
72 SOMNOLENCE 4
73 STRESS 4
74 THERAPEUTIC RESPONSE SHORTENED 4
75 TREMOR 4
76 VISION BLURRED 4
77 WEIGHT DECREASED 4
78 ABDOMINAL PAIN UPPER 3
79 ALOPECIA 3
80 AMNESIA 3
81 BLADDER DISORDER 3
82 BLOOD PRESSURE INCREASED 3
83 CHEST DISCOMFORT 3
84 CHILLS 3
85 DEPRESSION 3
86 DRY SKIN 3
87 HEART RATE INCREASED 3
88 HICCUPS 3
89 INCORRECT DRUG ADMINISTRATION RATE 3
90 INFLUENZA 3
91 INFUSION SITE PAIN 3
92 INJECTION SITE DISCOMFORT 3
93 INJECTION SITE WARMTH 3
94 MEMORY IMPAIRMENT 3
95 MUSCULOSKELETAL CHEST PAIN 3
96 PRODUCT ADMINISTRATION ERROR 3
97 PRODUCT DOSE OMISSION ISSUE 3
98 RHINORRHOEA 3
99 TEMPERATURE INTOLERANCE 3
100 B-LYMPHOCYTE COUNT DECREASED 2
101 BALANCE DISORDER 2
102 BODY TEMPERATURE INCREASED 2
103 CELLULITIS 2
104 CONTRAINDICATED PRODUCT ADMINISTERED 2
105 CYSTITIS 2
106 DEMYELINATION 2
107 DISEASE PROGRESSION 2
108 DRUG INTOLERANCE 2
109 DYSGEUSIA 2
110 ELECTRIC SHOCK SENSATION 2
111 FEELING ABNORMAL 2
112 FEELING HOT 2
113 GAIT INABILITY 2
114 GASTROINTESTINAL DISORDER 2
115 HYPERHIDROSIS 2
116 ILL-DEFINED DISORDER 2
117 IMMUNE SYSTEM DISORDER 2
118 IMMUNODEFICIENCY 2
119 IMMUNOSUPPRESSION 2
120 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
121 INJECTION SITE INDURATION 2
122 INJECTION SITE MASS 2
123 LYMPHOCYTE COUNT DECREASED 2
124 MASS 2
125 MUSCLE FATIGUE 2
126 MUSCULOSKELETAL STIFFNESS 2
127 NECK PAIN 2
128 NIGHT SWEATS 2
129 OROPHARYNGEAL PAIN 2
130 PALLOR 2
131 PERIPHERAL SWELLING 2
132 PHARYNGEAL SWELLING 2
133 PRODUCT PREPARATION ERROR 2
134 SCAR 2
135 SEASONAL ALLERGY 2
136 SEIZURE 2
137 SENSITIVE SKIN 2
138 SENSORY LOSS 2
139 SINUSITIS 2
140 SLEEP DISORDER 2
141 TACHYCARDIA 2
142 TENDERNESS 2
143 URINARY INCONTINENCE 2
144 ABDOMINAL MASS 1
145 ABDOMINAL TENDERNESS 1
146 ADMINISTRATION SITE IRRITATION 1
147 ADMINISTRATION SITE PAIN 1
148 ADMINISTRATION SITE PRURITUS 1
149 ADVERSE DRUG REACTION 1
150 AGGRESSION 1
151 ALANINE AMINOTRANSFERASE INCREASED 1
152 ANAL INCONTINENCE 1
153 ANTIBIOTIC THERAPY 1
154 APPENDICECTOMY 1
155 APPENDICITIS 1
156 ARTHROPOD BITE 1
157 ASPARTATE AMINOTRANSFERASE INCREASED 1
158 ASTHENOPIA 1
159 ASTHMA 1
160 ATRIOVENTRICULAR BLOCK 1
161 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1
162 ATYPICAL PNEUMONIA 1
163 BLINDNESS 1
164 BLISTER 1
165 BLOOD ALBUMIN DECREASED 1
166 BLOOD CALCIUM INCREASED 1
167 BLOOD CREATININE DECREASED 1
168 BLOOD PARATHYROID HORMONE DECREASED 1
169 BLOOD PRESSURE SYSTOLIC DECREASED 1
170 BLOOD TESTOSTERONE DECREASED 1
171 BODY HEIGHT DECREASED 1
172 BONE SWELLING 1
173 BREAST CANCER 1
174 BRONCHITIS 1
175 BRUXISM 1
176 CARDIAC OUTPUT DECREASED 1
177 CATARACT 1
178 CENTRAL NERVOUS SYSTEM LESION 1
179 CEREBRAL DISORDER 1
180 CHEST PAIN 1
181 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
182 CLOSTRIDIUM DIFFICILE INFECTION 1
183 CLUMSINESS 1
184 COGNITIVE DISORDER 1
185 COLITIS 1
186 COLON CANCER 1
187 CONFUSIONAL STATE 1
188 CONSTIPATION 1
189 COVID-19 PNEUMONIA 1
190 DEAFNESS 1
191 DEAFNESS UNILATERAL 1
192 DEATH 1
193 DECREASED ACTIVITY 1
194 DEEP VEIN THROMBOSIS 1
195 DEHYDRATION 1
196 DELIRIUM 1
197 DESQUAMATIVE INFLAMMATORY VAGINITIS 1
198 DEVICE DELIVERY SYSTEM ISSUE 1
199 DEVICE FAILURE 1
200 DIABETES MELLITUS 1
201 DIVERTICULITIS 1
202 DRY THROAT 1
203 DYSARTHRIA 1
204 DYSGRAPHIA 1
205 DYSMETRIA 1
206 DYSPHAGIA 1
207 DYSSTASIA 1
208 EAR PAIN 1
209 EAR PRURITUS 1
210 EMOTIONAL DISTRESS 1
211 ENERGY INCREASED 1
212 EPINEPHRINE DECREASED 1
213 ESCHERICHIA INFECTION 1
214 EYE MOVEMENT DISORDER 1
215 EYELID MARGIN CRUSTING 1
216 FACIAL DISCOMFORT 1
217 FACIAL PARALYSIS 1
218 FEAR OF INJECTION 1
219 FEBRILE NEUTROPENIA 1
220 FIBROMYALGIA 1
221 FIBULA FRACTURE 1
222 FLATULENCE 1
223 FLUID RETENTION 1
224 FREEZING PHENOMENON 1
225 FRUSTRATION TOLERANCE DECREASED 1
226 FUNGAL INFECTION 1
227 GASTROENTERITIS VIRAL 1
228 GINGIVAL PAIN 1
229 GRANULOCYTOSIS 1
230 HAEMATOCHEZIA 1
231 HAEMATOMA 1
232 HALLUCINATION 1
233 HEAD INJURY 1
234 HEART RATE DECREASED 1
235 HERPES ZOSTER 1
236 HIP FRACTURE 1
237 HOT FLUSH 1
238 HUNGER 1
239 HYPERPARATHYROIDISM 1
240 HYPERTENSION 1
241 HYPERTRANSAMINASAEMIA 1
242 HYPOACUSIS 1
243 HYPOTONIA 1
244 INFECTION 1
245 INFLAMMATION 1
246 INFUSION SITE HAEMATOMA 1
247 INFUSION SITE SWELLING 1
248 INJECTION SITE INFLAMMATION 1
249 INJECTION SITE IRRITATION 1
250 INJECTION SITE OEDEMA 1
251 INJECTION SITE PAPULE 1
252 INJECTION SITE SCAR 1
253 INJECTION SITE URTICARIA 1
254 INJECTION SITE VESICLES 1
255 INTERCEPTED PRODUCT STORAGE ERROR 1
256 IRRITABILITY 1
257 IRRITABLE BOWEL SYNDROME 1
258 JC POLYOMAVIRUS TEST POSITIVE 1
259 JOINT INSTABILITY 1
260 JOINT SWELLING 1
261 LABELLED DRUG-DRUG INTERACTION ISSUE 1
262 LACRIMATION INCREASED 1
263 LIBIDO DECREASED 1
264 LIMB MASS 1
265 LOCALISED INFECTION 1
266 LYMPHOEDEMA 1
267 MATERNAL EXPOSURE BEFORE PREGNANCY 1
268 MATERNAL EXPOSURE TIMING UNSPECIFIED 1
269 MEDICATION ERROR 1
270 MENINGITIS 1
271 MENISCUS INJURY 1
272 MENTAL FATIGUE 1
273 MENTAL IMPAIRMENT 1
274 MONOPARESIS 1
275 MOVEMENT DISORDER 1
276 MUSCLE RUPTURE 1
277 MUSCLE SPASMS 1
278 MUSCLE SPASTICITY 1
279 MUSCULOSKELETAL DISCOMFORT 1
280 MYALGIA 1
281 MYELOPATHY 1
282 MYOCARDIAL INFARCTION 1
283 NEPHROLITHIASIS 1
284 NERVOUS SYSTEM DISORDER 1
285 NEURALGIA 1
286 NEUTROPENIA 1
287 NEUTROPHIL COUNT DECREASED 1
288 NOROVIRUS INFECTION 1
289 OBESITY 1
290 OCULAR DISCOMFORT 1
291 OCULAR HYPERAEMIA 1
292 OEDEMA 1
293 OPTIC NEURITIS 1
294 OSTEOPENIA 1
295 OSTEOPOROSIS 1
296 OXYGEN SATURATION DECREASED 1
297 PAIN IN JAW 1
298 PARAESTHESIA ORAL 1
299 PARAGANGLION NEOPLASM 1
300 PARANASAL SINUS HYPERSECRETION 1
301 PATERNAL EXPOSURE BEFORE PREGNANCY 1
302 PATERNAL EXPOSURE DURING PREGNANCY 1
303 PERONEAL NERVE PALSY 1
304 PLEURAL EFFUSION 1
305 POLLAKIURIA 1
306 POOR VENOUS ACCESS 1
307 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
308 PRODUCT DOSE OMISSION IN ERROR 1
309 PROTEIN TOTAL DECREASED 1
310 PSYCHOTIC DISORDER 1
311 RASH ERYTHEMATOUS 1
312 RASH PRURITIC 1
313 RASH VESICULAR 1
314 RENAL DISORDER 1
315 RESPIRATORY DISORDER 1
316 RESTLESSNESS 1
317 RHEUMATOID ARTHRITIS 1
318 SARS-COV-2 TEST POSITIVE 1
319 SCHIZOAFFECTIVE DISORDER 1
320 SENSORY DISTURBANCE 1
321 SEPSIS 1
322 SINUS DISORDER 1
323 SJOGREN^S SYNDROME 1
324 SKIN BURNING SENSATION 1
325 SKIN DISORDER 1
326 SKIN INDURATION 1
327 SKIN INFECTION 1
328 SKIN WARM 1
329 SLOW SPEECH 1
330 SNEEZING 1
331 SPEECH DISORDER 1
332 SPINAL DISORDER 1
333 SQUAMOUS CELL CARCINOMA OF SKIN 1
334 STOMACH MASS 1
335 SUICIDE ATTEMPT 1
336 SUPERFICIAL VEIN THROMBOSIS 1
337 SWELLING FACE 1
338 SYNCOPE 1
339 THERAPEUTIC RESPONSE DECREASED 1
340 THERAPY CESSATION 1
341 THROMBOSIS 1
342 THROMBOTIC STROKE 1
343 TINNITUS 1
344 TOOTH FRACTURE 1
345 TRIGEMINAL NEURALGIA 1
346 TYPE IV HYPERSENSITIVITY REACTION 1
347 UHTHOFF^S PHENOMENON 1
348 UPPER RESPIRATORY TRACT INFECTION 1
349 UTERINE CYST 1
350 VAGINAL DISORDER 1
351 VASCULAR INJURY 1
352 VERTIGO 1
353 VESTIBULAR MIGRAINE 1
354 VIRAL INFECTION 1
355 VISUAL IMPAIRMENT 1
356 VITAMIN B1 DEFICIENCY 1
357 VITAMIN D DEFICIENCY 1
358 VOMITING PROJECTILE 1
359 WEIGHT FLUCTUATION 1
360 WHITE BLOOD CELL COUNT DECREASED 1
361 WHITE BLOOD CELL COUNT INCREASED 1
362 WHITE MATTER LESION 1